Generic medicine

Imeglimin Hydrochloride: Brands, Price & Uses in Bangladesh

Imeglimin Hydrochloride is indicated for the management of type 2 diabetes mellitus (T2DM) in adults, used to improve glycemic control alongside diet and exercise.

Forms:Tablet

About Imeglimin Hydrochloride

Indications of Imeglimin Hydrochloride

Imeglimin Hydrochloride is indicated for the management of type 2 diabetes mellitus (T2DM) in adults, used to improve glycemic control alongside diet and exercise.

  • Guideline/approved use: As monotherapy in patients with type 2 diabetes who have inadequate glycemic control on diet and exercise alone, particularly where metformin is not tolerated or is contraindicated.
  • Combination use: As an add-on to other oral antidiabetic agents (such as metformin, sulfonylureas, or DPP-4 inhibitors) or to insulin, when monotherapy does not achieve adequate glycemic control.

Imeglimin Hydrochloride belongs to a relatively new therapeutic class, and its place in overall diabetes treatment algorithms is still evolving as more clinical experience accumulates. It is not indicated for type 1 diabetes or diabetic ketoacidosis.

Dosage & Administration of Imeglimin Hydrochloride

Dosing of Imeglimin Hydrochloride should always be individualized by the prescribing physician based on glycemic response and tolerability.

IndicationTypical Adult Dosage
Type 2 diabetes mellitus (monotherapy or combination)1000 mg taken orally twice daily (morning and evening), with or without food, as advised by the physician

Renal impairment: Not recommended in patients with severe renal impairment (see Contraindications); dose adjustment or physician review is advised in mild-to-moderate renal impairment.

Hepatic impairment: Use with caution and under close physician supervision in patients with hepatic impairment, given limited data.

Pediatric use: Safety and efficacy have not been established in children (see Use in Special Populations).

Side Effects of Imeglimin Hydrochloride

Reported adverse effects with Imeglimin Hydrochloride include:

  • Gastrointestinal: Nausea, diarrhea, constipation, and abdominal discomfort are the most commonly reported effects.
  • Hypoglycemia: Primarily when used in combination with insulin or sulfonylureas.
  • Rare/theoretical: Lactic acidosis — a rare but serious risk considered on the basis of the drug's mitochondrial mechanism shared with biguanides, particularly in patients with predisposing conditions (see Precautions and Warnings).

Patients should report persistent gastrointestinal symptoms, unusual muscle pain, breathing difficulty, or unexplained fatigue promptly to their physician.

Contraindications of Imeglimin Hydrochloride

  • Known hypersensitivity to Imeglimin Hydrochloride or any component of the formulation.
  • Type 1 diabetes mellitus or diabetic ketoacidosis (DKA).
  • Severe renal impairment (including end-stage renal disease/dialysis), due to insufficient safety data and theoretical risk of drug accumulation and lactic acidosis.

Frequently Asked Questions about Imeglimin Hydrochloride

What is Imeglimin Hydrochloride used for?

Imeglimin Hydrochloride is used to help control blood glucose levels in adults with type 2 diabetes mellitus, either alone or in combination with other antidiabetic medicines.

How should I take Imeglimin Hydrochloride?

Imeglimin Hydrochloride is usually taken as a 1000 mg tablet by mouth twice daily, morning and evening, with or without food, exactly as prescribed by your physician.

Can Imeglimin Hydrochloride cause low blood sugar (hypoglycemia)?

Imeglimin Hydrochloride alone has a low risk of causing hypoglycemia, but the risk increases when it is combined with insulin or sulfonylurea medicines. Discuss symptoms and management of hypoglycemia with your physician.

Who should not take Imeglimin Hydrochloride?

Imeglimin Hydrochloride should not be used by people with known hypersensitivity to it, those with type 1 diabetes or diabetic ketoacidosis, or those with severe kidney impairment.

Is Imeglimin Hydrochloride safe during pregnancy or breastfeeding?

Imeglimin Hydrochloride should be used in pregnancy only if clearly needed and if the potential benefit outweighs potential risk, as safety data in pregnant women are limited; insulin is generally preferred during pregnancy. Whether it passes into breast milk is not well established, so consult your physician before use while breastfeeding.

What side effects should I watch for with Imeglimin Hydrochloride?

The most common side effects are gastrointestinal, such as nausea, diarrhea, and constipation. Rarely, because of its mechanism related to biguanides, there is a theoretical risk of lactic acidosis, especially in people with kidney or liver problems, or conditions causing low oxygen levels. Seek medical attention promptly for unusual muscle pain, difficulty breathing, or severe fatigue.

Disclaimer

The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.

DoctorBlogArticles